Polymorphisms in the IL‐1 gene cluster influence systemic inflammation in patients at risk for acute‐on‐chronic liver failure
暂无分享,去创建一个
A. de Gottardi | M. Pavesi | V. Arroyo | H. Grønbaek | J. Clària | P. Ginès | M. Bernardi | E. Titos | C. López-Vicario | I. Graziadei | M. Casulleras | José Alcaraz-Quiles | Bibiana Rius | A. Lopategi | Cristina López-Vicario | P. Ginés | Cristina López‐Vicario | C. López‐Vicario
[1] Richard Moreau,et al. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.
[2] J. Silke,et al. Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis , 2015, Current opinion in hematology.
[3] G. Auzinger,et al. University of Birmingham Patients With Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK , 2014 .
[4] R. Parkhouse,et al. Insights into the molecular basis of the NOD2 signalling pathway , 2014, Open Biology.
[5] S. Rajasekaran,et al. Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children* , 2014, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[6] Vishva M. Dixit,et al. Mechanisms and Functions of Inflammasomes , 2014, Cell.
[7] D. Vaux,et al. RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis , 2014, Cell.
[8] K. Massey,et al. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2 , 2014, Nature Medicine.
[9] M. Rottenberg,et al. SOCS3, a Major Regulator of Infection and Inflammation , 2014, Front. Immunol..
[10] C. Garlanda,et al. The interleukin-1 family: back to the future. , 2013, Immunity.
[11] R. Moreau,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.
[12] P. Hedrick. What is the evidence for heterozygote advantage selection? , 2012, Trends in ecology & evolution.
[13] R. Medzhitov. Inflammation 2010: New Adventures of an Old Flame , 2010, Cell.
[14] C. Dinarello. Interleukin-1beta and the autoinflammatory diseases. , 2009, The New England journal of medicine.
[15] J. Singh,et al. Anakinra for Rheumatoid Arthritis: A Systematic Review , 2009, The Journal of Rheumatology.
[16] Jayne Jones,et al. Cytokine Gene Polymorphisms in Heavy Drinkers With and Without Decompensated Liver Disease: A Case-Control Study , 2008, The American Journal of Gastroenterology.
[17] P. Ridker,et al. Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach. , 2008, Atherosclerosis.
[18] A. Roddam,et al. Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. , 2008, Rheumatology.
[19] Peter A. Ward,et al. Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.
[20] D. Raoult,et al. The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.
[21] R. González-Sarmiento,et al. Interleukin-1 gene cluster polymorphisms and alcoholism in Spanish men. , 2005, Alcohol and alcoholism.
[22] A. Sher,et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.
[23] F. Lammert,et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. , 2005, Journal of hepatology.
[24] Ping Wang,et al. Correlation of polymorphism in the interleukin-1 receptor antagonist gene intron 2 with alcoholic liver disease. , 2005, Hepatobiliary & pancreatic diseases international : HBPD INT.
[25] M. Manns,et al. Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C. , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[26] J. Sims,et al. Annotating genes with potential roles in the immune system: six new members of the IL-1 family. , 2001, Trends in immunology.
[27] F. Pociot,et al. Cytokine gene polymorphism in human disease: on-line databases , 1999, Genes and Immunity.
[28] P. Hertzog,et al. Recent advances in cytokines, cytokine receptors and signal transduction. , 1998, Cytokine & growth factor reviews.
[29] S. Saitoh,et al. Correlation of a polymorphism in the interleukin-1 receptor antagonist gene with hepatic fibrosis in Japanese alcoholics. , 1998, Alcoholism, clinical and experimental research.
[30] C. Gabay,et al. Interleukin-1 receptor antagonist: role in biology. , 1998, Annual review of immunology.
[31] S. Opal,et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. , 1997, Critical care medicine.
[32] C. Gabay,et al. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. , 1997, The Journal of clinical investigation.
[33] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[34] R. F. Johnston,et al. Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .
[35] S. Opal,et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. , 1994, JAMA.
[36] G. Tosato,et al. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. , 1990, Blood.
[37] J. Meer,et al. Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods. , 1988, Lymphokine research.
[38] C. Avnstorp,et al. Interleukin‐1 , 1987 .